AI in 2026 is moving past ageing clocks that spit out a single number towards foundation models that reason about biological age, predict disease and nominate targets. Here is what changed and why it matters.
A Nature Medicine study trained AI on 25,712 human tissue slides and found that organs keep separate biological clocks. Some of that signal shows up in a blood sample. What it means, and what it does not.
Genentech validated the first AI-discovered neuroscience drug target from its $12B Recursion partnership. A proof point the AI-drug discovery field needed.
VirTues, a new foundation model published in Nature, learns one shared representation of spatial proteomics data across marker panels and imaging platforms—and finds biomarkers that predict immunotherapy response.
